Literature DB >> 8881764

A defect in inducible beta-galactosidase of B lymphocytes in the osteopetrotic (mi/mi) mouse.

N Yamamoto1, V R Naraparaju.   

Abstract

Macrophages were activated by administration of an inflammatory lipid metabolite, lysophosphatidylcholine (lyso-Pc), to wild type mice but not murine (microphthalmic) osteopetrotic (mi/mi) mutant mice. In vitro treatment of wild type mouse peritoneal cells with lyso-Pc efficiently activated macrophages whereas lyso-Pc-treatment of mi mutant mouse peritoneal cells resulted in no activation of macrophages. Generation of macrophage activating factor requires a precursor protein, serum vitamin D binding protein (DBP), and participation of lyso-Pc-inducible beta-galactosidase of B lymphocytes. Lyso-Pc-inducible beta-galactosidase of B lymphocytes was found to be defective in mi mutant mice.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8881764      PMCID： PMC1456628          DOI： 10.1046/j.1365-2567.1996.d01-684.x

Source DB:  PubMed          Journal:  Immunology        ISSN： 0019-2805            Impact factor:   7.397


  30 in total

1.  Circulating macrophage colony-stimulating factor is not reduced in malignant osteopetrosis.

Authors:  P J Orchard; N Dahl; S L Aukerman; B R Blazar; L L Key
Journal:  Exp Hematol       Date:  1992-01       Impact factor: 3.084

2.  Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse.

Authors:  W Wiktor-Jedrzejczak; A Bartocci; A W Ferrante; A Ahmed-Ansari; K W Sell; J W Pollard; E R Stanley
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

3.  Identification of the serum factor required for in vitro activation of macrophages. Role of vitamin D3-binding protein (group specific component, Gc) in lysophospholipid activation of mouse peritoneal macrophages.

Authors:  N Yamamoto; S Homma; I Millman
Journal:  J Immunol       Date:  1991-07-01       Impact factor: 5.422

4.  Conversion of vitamin D3 binding protein (group-specific component) to a macrophage activating factor by the stepwise action of beta-galactosidase of B cells and sialidase of T cells.

Authors:  N Yamamoto; R Kumashiro
Journal:  J Immunol       Date:  1993-09-01       Impact factor: 5.422

5.  The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene.

Authors:  H Yoshida; S Hayashi; T Kunisada; M Ogawa; S Nishikawa; H Okamura; T Sudo; L D Shultz; S Nishikawa
Journal:  Nature       Date:  1990-05-31       Impact factor: 49.962

6.  A defect in the inflammation-primed macrophage-activation cascade in osteopetrotic rats.

Authors:  N Yamamoto; D D Lindsay; V R Naraparaju; R A Ireland; S N Popoff
Journal:  J Immunol       Date:  1994-05-15       Impact factor: 5.422

7.  Regulation of inflammation-primed activation of macrophages by two serum factors, vitamin D3-binding protein and albumin.

Authors:  N Yamamoto; R Kumashiro; M Yamamoto; N P Willett; D D Lindsay
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

8.  Vitamin D-binding protein (group-specific component) is the sole serum protein required for macrophage activation after treatment of peritoneal cells with lysophosphatidylcholine.

Authors:  S Homma; M Yamamoto; N Yamamoto
Journal:  Immunol Cell Biol       Date:  1993-08       Impact factor: 5.126

9.  Correction by CSF-1 of defects in the osteopetrotic op/op mouse suggests local, developmental, and humoral requirements for this growth factor.

Authors:  W Wiktor-Jedrzejczak; E Urbanowska; S L Aukerman; J W Pollard; E R Stanley; P Ralph; A A Ansari; K W Sell; M Szperl
Journal:  Exp Hematol       Date:  1991-11       Impact factor: 3.084

10.  Vitamin D3 binding protein (group-specific component) is a precursor for the macrophage-activating signal factor from lysophosphatidylcholine-treated lymphocytes.

Authors:  N Yamamoto; S Homma
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205
View more
  2 in total

Review 1.  Combination approaches to potentiate immune response after photodynamic therapy for cancer.

Authors:  Tyler G St Denis; Kanza Aziz; Anam A Waheed; Ying-Ying Huang; Sulbha K Sharma; Pawel Mroz; Michael R Hamblin
Journal:  Photochem Photobiol Sci       Date:  2011-04-09       Impact factor: 3.982

2.  A bone substitute with high affinity for vitamin D-binding protein--relationship with niche of osteoclasts.

Authors:  Tohru Ikeda; Michiyuki Kasai; Eri Tatsukawa; Masanobu Kamitakahara; Yasuaki Shibata; Taishi Yokoi; Takayuki K Nemoto; Koji Ioku
Journal:  J Cell Mol Med       Date:  2013-11-28       Impact factor: 5.310
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.